The historical rank and industry rank for Reviva Pharmaceuticals Holdings's PB Ratio or its related term are showing as below:
RVPH'
s PB Ratio Range Over the Past 10 Years
Min: 0 Med: 0 Max: 0.5
Current: 0.49
During the past 7 years, Reviva Pharmaceuticals Holdings's highest PB Ratio was 0.50. The lowest was 0.00. And the median was 0.00.
RVPH's PB Ratio is ranked better than 95.54% of 1232
companies
in the Biotechnology industry
Industry Median: 2.8
vs RVPH: 0.49
During the past 12 months, Reviva Pharmaceuticals Holdings's average Book Value Per Share Growth Rate was 322.10% per year.
During the past 3 years, the average Book Value Per Share Growth Rate was -43.60% per year.
During the past 5 years, the average Book Value Per Share Growth Rate was -51.50% per year.
During the past 7 years, the highest 3-Year average Book Value Per Share Growth Rate of Reviva Pharmaceuticals Holdings was -29.80% per year. The lowest was -79.40% per year. And the median was -43.60% per year.
Back to Basics: PB Ratio
Reviva Pharmaceuticals Holdings (OTCPK:RVPH) PB Ratio Explanation
The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.
Be Aware
Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.
Reviva Pharmaceuticals Holdings PB Ratio Related Terms
Reviva Pharmaceuticals Holdings PB Ratio Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Biotechnology subindustry, Reviva Pharmaceuticals Holdings's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Reviva Pharmaceuticals Holdings PB Ratio vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Reviva Pharmaceuticals Holdings's PB Ratio distribution charts can be found below:
* The bar in red indicates where Reviva Pharmaceuticals Holdings's PB Ratio falls into.
Reviva Pharmaceuticals Holdings PB Ratio Calculation
The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.
Reviva Pharmaceuticals Holdings (RVPH) has a PB Ratio of 0.49 as of Jun. 26, 2026. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on Reviva Pharmaceuticals Holdings and its competitors. According to the industry distribution chart, Reviva Pharmaceuticals Holdings ranks #55 out of 1232 companies in the Biotechnology industry, placing it in the top 4.5%.
Is Reviva Pharmaceuticals Holdings' PB Ratio too high?
Reviva Pharmaceuticals Holdings' current PB Ratio is 0.49. The Biotechnology industry median PB Ratio is 2.80. Reviva Pharmaceuticals Holdings' value of 0.49 is 82.5% below this industry median. Based on the distribution chart, Reviva Pharmaceuticals Holdings ranks #55 out of 1232 companies in the Biotechnology industry, which is in the top quartile — a strong position relative to peers. Overall, Reviva Pharmaceuticals Holdings has a GF Score™ of 22/100, reflecting its overall financial health beyond just this single metric.
How does Reviva Pharmaceuticals Holdings' PB Ratio compare to MLEC and DRMA?
According to the Biotechnology industry distribution chart, Reviva Pharmaceuticals Holdings ranks #55 out of 1232 companies for PB Ratio. This places Reviva Pharmaceuticals Holdings in the top 5% of its industry — outperforming the majority of peers. The industry median PB Ratio is 2.80. Reviva Pharmaceuticals Holdings' value of 0.49 is 82.5% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PB Ratio for a Biotechnology company?
The median PB Ratio among Biotechnology companies is 2.80, based on 1,232 companies in the industry. Companies in the top quartile (top 25%) have a PB Ratio significantly above this median, while those in the bottom quartile fall well below. However, PB Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Reviva Pharmaceuticals Holdings's current PB Ratio of 0.49 is 82.5% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PB Ratio mean?
A high PB Ratio can signal that a stock is expensive relative to its fundamentals. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on Reviva Pharmaceuticals Holdings and its competitors. For the Biotechnology industry, the median PB Ratio is 2.80 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Reviva Pharmaceuticals Holdings's current PB Ratio is 0.49. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Reviva Pharmaceuticals Holdings stock overvalued right now?
Reviva Pharmaceuticals Holdings (RVPH) has a current PB Ratio of 0.49. The current PB Ratio is 0.49 and 82.5% below the Biotechnology industry median of 2.80. Reviva Pharmaceuticals Holdings' overall GF Score™ is 22/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PB Ratio calculated?
PB Ratio is calculated from a company's financial statements. For Reviva Pharmaceuticals Holdings (RVPH), the current PB Ratio is 0.49 as of Jun. 26, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Reviva Pharmaceuticals Holdings Business Description
Reviva Pharmaceuticals Holdings Inc is a late-stage pharmaceutical company that discovers, develops, and seeks to commercialize therapeutics for diseases. The current pipeline of the company focuses on the central nervous system, inflammatory, and cardiometabolic diseases. The company uses a chemical genomics-driven technology platform and proprietary chemistry to develop new medicines. The company's pipeline currently has two drug candidates, Brilaroxazine (RP5063), which is intended to treat multiple neuropsychiatric indications, including schizophrenia, bipolar disorder, depressive disorder, attention-deficit/hyperactivity disorder, behavioral and psychotic symptoms of dementia or Alzheimer's disease, and Parkinson's disease psychosis, and its other drug candidate is RP1208.
22GF Score
Get the complete analysis for RVPH
PB Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
RVPH has been successfully added to your 
